Formulation and In-Vitro Evaluation of immediate-release pellets of Candesartan Cilexetil

Authors

  • Goparaju Suryanarayana Murthy CMR Technical Campus Autonomous, Medchal Road, Kandlakoya, Hyderabad-501401, Telangana State, India

Abstract

Multi particulate drug delivery system has long run also been made use of to enhance the overall bioavailability going from drugs having low aqueous solubility. Candesartan Cilexetil is an anti-hypertensive drug. Complex and dispersion of Candesartan Cilexetil with the different carriers were prepared to increase its solubility and bioavailability. Due to its low aqueous solubility bioavailability of the drug is 15 % and it shows variable absorption from GIT. Pellets offer several advantages such as proper distribution in the GIT tract, reduces dose dumping, and relief going from administration as well as closing going from chemotherapy therefore within the time being work an immediate-release Pellets of candesartan cilexetil was planned out using the representational of increasing the solubility and in turn bioavailability of Candesartan Cilexetil. Immediate release Pellets containing complex or dispersion of Candesartan Cilexetil with the suitable carrier was prepared using non-pareil sugar seeds. On the non-pareil seeds, drug layering of Candesartan Cilexetil complexed or dispersed with the suitable carrier was done. The formulation having Candesartan Cilexetil and Eudragit dispersed in 1:3 ratios is considered the best product concerning assay and in-vitro drug release. The present top of the line used to be promote withstand constancy written report, the results of and that indicated no important change concerning assay, content uniformity, and in vitro drug release.

Keywords:

Candesartan Cilexetil, PEG 8000, ?-Cyclodextrine, HPMC, Eudragit, Pellets

Downloads

Download data is not yet available.

Published

2021-01-18

How to Cite

Goparaju Suryanarayana Murthy. (2021). Formulation and In-Vitro Evaluation of immediate-release pellets of Candesartan Cilexetil. Future Journal of Pharmaceuticals and Health Sciences, 1(1), 11–20. Retrieved from http://pharmasprings.com/index.php/fjphs/article/view/3

Issue

Section

Original Articles